Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 May;41(5):745–750. doi: 10.1038/bjc.1980.136

Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma.

H K Silver, K A Karim, F A Salinas
PMCID: PMC2010328  PMID: 6158966

Abstract

Reported elevations of total serum sialic acid may be a result of shed tumour-related membrane sialyglycoprotein and/or concurrent elevation of non-specific, acute-phase reactant sialoglycoprotein. To clarify further the specificity and sensitivity of serum sialic acid monitoring, analyses of sialic acid by the thiobarbituric acid method and acute-phase reactants by radial immunodiffusion were made using the same malignant melanoma patients' sera. Preliminary studies of IgG, IgA, IgM, ceruloplasmin and C-reactive protein suggested that these would not be valuable monitors of tumour burden. Single serum samples from 59 melanoma patients and age- and sex-matched controls were further examined for sialic acid, alpha 1-acid glycoprotein, alpha 1-antitrypsin, haptoglobin, and alpha 2-macroglobulin. Patients were grouped according to tumour burden. In pairwise statistical tests, differences between groups tended to be greater for sialic acid than for acute-phase reactants. On discriminant analysis , sialic acid was clearly the most significant single discriminator between groups, with an F statistic of P < 0.00005. Although alpha 1-acid glycoprotein was quite strongly correlated with sialic acid, it was not such a good discriminator and did not add significantly to the predictive power of sialic acid alone.

Full text

PDF
746

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhavanandan V. P., Umemoto J., Banks J. R., Davidson E. A. Isolation and partial characterization of sialoglycopeptides produced by a murine melanoma. Biochemistry. 1977 Oct 4;16(20):4426–4437. doi: 10.1021/bi00639a016. [DOI] [PubMed] [Google Scholar]
  2. Child J. A., Roberts B. E., Illingworth S., Cooper E. H. Acute phase reactant proteins in chronic leukaemia. Biomedicine. 1977 Jul;27(5):188–190. [PubMed] [Google Scholar]
  3. Coombes R. C., Powles T. J., Gazet J. C., Ford H. T., Sloane J. P., Laurence D. J., Neville A. M. Biochemical markers in human breast cancer. Lancet. 1977 Jan 15;1(8003):132–134. doi: 10.1016/s0140-6736(77)91719-6. [DOI] [PubMed] [Google Scholar]
  4. Dhar P., Moore T., Zamcheck N., Kupchik H. Z. Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA. 1972 Jul 3;221(1):31–35. [PubMed] [Google Scholar]
  5. Grimm E. A., Silver H. K., Roth J. A., Chee D. O., Gupta R. K., Morton D. L. Detection of tumor-associated antigen in human melanoma cell line supernatants. Int J Cancer. 1976 May 15;17(5):559–564. doi: 10.1002/ijc.2910170503. [DOI] [PubMed] [Google Scholar]
  6. Hollinshead A. C., Chuang C. Y., Cooper E. H., Catalona W. J. Interrelationship of prealbumin and alpha-1 acid glycoprotein in cancer patient sera. Cancer. 1977 Dec;40(6):2993–2998. doi: 10.1002/1097-0142(197712)40:6<2993::aid-cncr2820400635>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Mabry E. W., Carubelli R. Sialic cid in human cancer. Experientia. 1972 Feb 15;28(2):182–183. [PubMed] [Google Scholar]
  8. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  9. Mueller W. K., Handschumacher R., Wade M. E. Serum haptoglobin in patients with ovarian malignancies. Obstet Gynecol. 1971 Sep;38(3):427–435. [PubMed] [Google Scholar]
  10. Parks L. C., Baer A. N., Pollack M., Williams G. M. Alpha Fetoprotein: An index of progression or regression of hepatoma, and a target for immunotherapy. Ann Surg. 1974 Oct;180(4):599–605. doi: 10.1097/00000658-197410000-00025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Silver H. K., Gold P., Feder S., Freedman S. O., Shuster J. Radioimmunoassay for human alpha 1 -fetoprotein. Proc Natl Acad Sci U S A. 1973 Feb;70(2):526–530. doi: 10.1073/pnas.70.2.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Silver H. K., Karim K. A., Archibald E. L., Salinas F. A. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Cancer Res. 1979 Dec;39(12):5036–5042. [PubMed] [Google Scholar]
  13. Silver H. K., Rangel D. M., Morton D. L. Serum sialic acid elevations in malignant melanoma patients. Cancer. 1978 Apr;41(4):1497–1499. doi: 10.1002/1097-0142(197804)41:4<1497::aid-cncr2820410438>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  14. Ward A. M., Cooper E. H., Houghton A. L. Acute phase reactant proteins in prostatic cancer. Br J Urol. 1977 Oct;49(5):411–418. doi: 10.1111/j.1464-410x.1977.tb04168.x. [DOI] [PubMed] [Google Scholar]
  15. Ward A. M., Cooper E. H., Turner R., Anderson J. A., Neville A. M. Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer. 1977 Feb;35(2):170–178. doi: 10.1038/bjc.1977.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Weiss J. F., Morantz R. A., Bradley W. P., Chretien P. B. Serum acute-phase proteins and immunoglobulins in patients with gliomas. Cancer Res. 1979 Feb;39(2 Pt 1):542–544. [PubMed] [Google Scholar]
  17. te Velde E. R., Berrens L., Zegers B. J., Ballieux R. E. Acute phase reactants and complement components as indicators of recurrence in human cervical cancer. Eur J Cancer. 1979 Jun;15(6):893–899. doi: 10.1016/0014-2964(79)90231-7. [DOI] [PubMed] [Google Scholar]
  18. van Beek W. P., Smets L. A., Emmelot P. Increased sialic acid density in surface glycoprotein of transformed and malignant cells--a general phenomenon? Cancer Res. 1973 Nov;33(11):2913–2922. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES